Several immunotherapies are now approved or explored in clinical trials. My research focus on combining these modalities in pre-clinical models as to set the next stage of clinical research. I am also exploring the role of vaccine to cancer testis antigens (NY-ESO-1) in combination with immune modulation. These pre-clinical studies will help instruct and inform the design of future clinical trials